Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 25, 2018

Effect of Melissa officinalis capsule on the mental health of female adolescents with premenstrual syndrome: a clinical trial study

  • Naval Heydari , Mansure Dehghani , Maasumeh Emamghoreishi and Marzieh Akbarzadeh EMAIL logo

Abstract

Introduction

In spite of its importance, the psychological health requirements of adolescents are ignored; due to the occurrence of mental disorders in this age group and also public interest in the use of supplementary and alternative treatments such as herbal drugs for mental disorders, this study was carried out aimed at examining the impact of the Melissa officinalis capsule on the psychological health of female adolescents.

Methodology

In this randomized clinical trial study, 100 female adolescents were assigned to two groups of either drug and placebo groups. The data collection tool includes demographic information recording note and General Health Standard Questionnaire (GHQ). Intervention has been done in the menstrual cycle during 3 successive months and patients received two 600 mg drug daily in the intervention group, and the control group received placebo. After the intervention, the scores of the participants’ psychological health were measured in both groups and data were analyzed through independent t-test using SPSS software version 16.

Results

The study results showed that psychosomatic symptoms score (p < 0.001), anxiety and sleeping disorder (p < 0.001), and social function disorder (p = 0.021) in the experiment group was significantly less than that of the placebo group.

Conclusion

Based on the findings of this study, Melissa officinalis can decrease psychosomatic symptoms, sleeping disorder and anxiety, depression and disorder in social function in female adolescents.

Acknowledgments

This article is a part of Mansoore Dehghani’s thesis (thesis number: 92-6805, IRCT: 2014060717998N1). Akbarzadeh et al. appreciate Research and Technology Department of Shiraz University of Medical Sciences. The authors would like to thank Shiraz University of Medical Sciences, Shiraz, Iran and also Center for Development of Clinical Research of Nemazee Hospital to help data analyze and Dr. Nasrin Shokrpour for editorial assistance.

[1] Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O, et al. Child and adolescent mental health worldwide: evidence for action. The Lancet. 2011;378:1515–25.10.1016/S0140-6736(11)60827-1Search in Google Scholar

[2] Brüssow H. What is health? Microb Biotechnol. 2013;6:341–348.10.1111/1751-7915.12063Search in Google Scholar PubMed

[3] Patel V, Flisher AJ, Hetrick S, McGorry P. Mental health of young people: a global public-health challenge. Lancet. 2007;369:1302–13.10.1016/S0140-6736(07)60368-7Search in Google Scholar PubMed

[4] Lopez A. Disease Control Priorities Project: global burden of disease and risk factors. Washington, DC: Oxford University Press. View Article Google Scholar 2006.10.1596/978-0-8213-6262-4Search in Google Scholar

[5] Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dickerson V, et al. Health and economic impact of the premenstrual syndrome. J Reprod Med. 2003;48:515–24.Search in Google Scholar PubMed

[6] Wong LP. Premenstrual syndrome and dysmenorrhea: urban-rural and multiethnic differences in perception, impacts, and treatment seeking. J Pediatr Adolesc Gynecol. 2011;24:272–7.10.1016/j.jpag.2011.03.009Search in Google Scholar PubMed

[7] Wittchen H-U, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32:119–32.10.1017/S0033291701004925Search in Google Scholar PubMed

[8] Gyllenhaal C, Merritt SL, Peterson SD, Block KI, Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev. 2000;4:229–51.10.1053/smrv.1999.0093Search in Google Scholar PubMed

[9] Simon GE, Cherkin DC, Sherman KJ, Eisenberg DM, Deyo RA, Davis RB. Mental health visits to complementary and alternative medicine providers. Gen Hosp Psychiatry. 2004;26:171–7.10.1016/j.genhosppsych.2004.01.002Search in Google Scholar PubMed

[10] Jorm AF, Allen NB, O Donnell CP, Parslow RA, Purcell R, Morgan AJ. Effectiveness of complementary and self-help treatments for depression in children and adolescents. Med J Aust. 2006;185:368.10.5694/j.1326-5377.2006.tb00612.xSearch in Google Scholar PubMed

[11] Soh NL, Walter G. Traditional and alternative medicine treatments in child and adolescent mental health. IACAPAP e-Textbook of Child and Adolescent Mental Health 2015.Search in Google Scholar

[12] Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders. Psychiatr Serv. 2000;51:1130–4.10.1176/appi.ps.51.9.1130Search in Google Scholar PubMed

[13] Abuhamdah S, Chazot PL. Lemon Balm and Lavender herbal essential oils: old and new ways to treat emotional disorders?. Curr Anaesth Crit Care. 2008;19:221–6.10.1016/j.cacc.2008.05.005Search in Google Scholar

[14] Kennedy D, Little W, Haskell CF, Scholey A. Anxiolytic effects of a combination of Melissa officinalis and Valerlana officinalis during laboratory induced stress. Phytother Res 2006;20(2):96–102.10.1002/ptr.1787Search in Google Scholar PubMed

[15] Kennedy D, Scholey AB, Tildesley N, Perry E, Wesnes K. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002;72:953–64.10.1016/S0091-3057(02)00777-3Search in Google Scholar PubMed

[16] Alramadhan E, Hanna MS, Hanna MS, Goldstein TG, Avila SM, Weeks BS. Dietary and botanical anxiolytics. Med Sci Monit. 2012;18:RA40–8.10.12659/MSM.882608Search in Google Scholar PubMed PubMed Central

[17] Krebs K. Complementary healthcare practices: stress management: the complementary alternative medicine approach. Gastroenterol Nurs. 2001;24:261–3.10.1097/00001610-200109000-00008Search in Google Scholar PubMed

[18] Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21:841–60.10.1016/j.euroneuro.2011.04.002Search in Google Scholar PubMed

[19] Yoo DY, Choi JH, Kim W, Yoo K-Y, Lee CH, Yoon YS, et al. Effects of Melissa officinalis L.(lemon balm) extract on neurogenesis associated with serum corticosterone and GABA in the mouse dentate gyrus. Neurochem Res. 2011;36:250–7.10.1007/s11064-010-0312-2Search in Google Scholar PubMed

[20] Bayat M, Tameh AA, Ghahremani MH, Akbari M, Mehr SE, Khanavi M, et al. Neuroprotective properties of Melissa officinalis after hypoxic-ischemic injury both in vitro and in vivo. DARU J Pharm Sci. 2012;20:42.10.1186/2008-2231-20-42Search in Google Scholar PubMed PubMed Central

[21] Hassanzadeh G, Pasbakhsh P, Akbari M, Shokri S, Ghahremani M, Amin G, et al. Neuroprotective properties of Melissa officinalis L. extract against ecstasy-induced neurotoxicity. Cell J (Yakhteh). 2011;13:25–30.Search in Google Scholar

[22] Goldberg LR. The development of markers for the Big-Five factor structure. Psychol Assess. 1992;4:26.10.1037/1040-3590.4.1.26Search in Google Scholar

[23] Ebrahimi A, Molavi H, Moosavi G, Bornamanesh A, Yaghobi M. Psychometric properties and factor structure of general health questionnaire 28 (GHQ-28) in Iranian psychiatric patients. J Res Behav Sci. 2007;5:5–12. (Persian).Search in Google Scholar

[24] Rapkin A, Winer S. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Rev Pharmacoecon Outcomes Res. 2009;9:157–70.10.1586/erp.09.14Search in Google Scholar PubMed

[25] Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Women’s Ment Health. 2003;6:203–9.10.1007/s00737-003-0018-4Search in Google Scholar

[26] Hariri FZ, Moghaddam-Banaem L, Bazi SS, Malehi AS, Montazeri A. The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study. Arch Women’s Ment Health. 2013;16:531–7.10.1007/s00737-013-0375-6Search in Google Scholar

[27] Alijaniha F, Naseri M, Afsharypuor S, Fallahi F, Noorbala A, Mosaddegh M, et al. Heart palpitation relief with Melissa officinalis leaf extract: double blind, randomized, placebo controlled trial of efficacy and safety. J Ethnopharmacol. 2015;164:378–84.10.1016/j.jep.2015.02.007Search in Google Scholar PubMed

[28] Scholey A, Gibbs A, Neale C, Perry N, Ossoukhova A, Bilog V, et al. Anti-stress effects of lemon balm-containing foods. Nutrients. 2014;6:4805–21.10.3390/nu6114805Search in Google Scholar PubMed

[29] Dimpfel W, Pischel I, Lehnfeld R. Effects of lozenge containing lavender oil, extracts from hops, lemon balm and oat on electrical brain activity of volunteers. Eur J Med Res. 2004;9:423–31.Search in Google Scholar PubMed

[30] Sarris J, Moylan S, Camfield DA, Pase M, Mischoulon D, Berk M, et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence. Evid Based Complement Altern Med. 2012;2012:809653.10.1155/2012/809653Search in Google Scholar

[31] Müller S, Klement S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine. 2006;13:383–7.10.1016/j.phymed.2006.01.013Search in Google Scholar PubMed

[32] Cerny A, Schmid K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study). Fitoterapia. 1999;70:221–8.10.1016/S0367-326X(99)00018-0Search in Google Scholar

[33] Taavoni S, Nazem Ekbatani N, Haghani H. The effect of lemon Balm on sleep disorder in menopausal women 60-50 years old. Complement Med J Fac Nurs Midwifery. 2013;2:344–54 [in Persian].Search in Google Scholar

[34] Cases J, Ibarra A, Feuillere N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterr J Nutr Metab. 2011;4:211–8.10.1007/s12349-010-0045-4Search in Google Scholar PubMed PubMed Central

[35] Heidari M, Soltanpour A, Naseri M, Kazemnejad A. The effect of Lemon Balm (Melissa Officinalis) on depression in patients after coronary artery bypass graft. Cardiovasc Nurs J. 2015;4:36–43 [in Persian].Search in Google Scholar

[36] Akbarzadeh M, Dehghani M, Moshfeghy Z, Emamghoreishi M, Tavakoli P, Zare N. Effect of Melissa officinalis capsule on the intensity of premenstrual syndrome symptoms in high school girl students. Nurs Midwifery Stud. 2015;e270014.10.17795/nmsjournal27001Search in Google Scholar PubMed PubMed Central

[37] Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT. Bioassay‐guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother Res. 2009;23:1075–81.10.1002/ptr.2712Search in Google Scholar PubMed

[38] López V, Martín S, Gómez-Serranillos MP, Carretero ME, Jäger AK, Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res. 2009;34:1955–61.10.1007/s11064-009-9981-0Search in Google Scholar PubMed

[39] Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: relarian. Med Sci Monit. 2009;15:RA256–62.Search in Google Scholar PubMed

[40] Jin X, Liu P, Yang F, Zhang Y-h, Miao D. Rosmarinic acid ameliorates depressive-like behaviors in a rat model of CUS and up-regulates BDNF levels in the hippocampus and hippocampal-derived astrocytes. Neurochem Res. 2013;38:1828–37.10.1007/s11064-013-1088-ySearch in Google Scholar PubMed

[41] Modaresi M, Basravi M, Sajadia I. Comparative effects of balm hydro alcoholic extract and diazepam on reducing anxiety of in mice. Armaghane Danesh. 2016;20:848–57.Search in Google Scholar

[42] Taiwo AE, Leite FB, Lucena GM, Barros M, Silveira D, Silva MV, et al. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: influence of administration and gender. Indian J Pharmacol. 2012;44:189.10.4103/0253-7613.93846Search in Google Scholar PubMed PubMed Central

[43] Limosin F, Ades J. [Psychiatric and psychological aspects of premenstrual syndrome]. L’Encephale. 2000;27:501–8.Search in Google Scholar

[44] Rapkin AJ, Akopians AL. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause Int. 2012;18:52–9.10.1258/mi.2012.012014Search in Google Scholar PubMed

[45] Amin Z, Canli T, Epperson CN. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev. 2005;4:43–58.10.1177/1534582305277152Search in Google Scholar PubMed

[46] Ballard CG, O Brien JT, Reichelt K, Perry EK. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. J Clin Psychiatry. 2002;63:553–8.10.4088/JCP.v63n0703Search in Google Scholar PubMed

Received: 2017-01-27
Accepted: 2017-05-26
Published Online: 2018-01-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 5.2.2023 from https://www.degruyter.com/document/doi/10.1515/ijamh-2017-0015/html
Scroll Up Arrow